2009; and the Clinical Research Forum and Foundation’s Annual Award for Leadership in Public Advocacy in 2011. She is also an Ashoka Fellow.
Myles Axton, Ph.D., is editor of Nature Genetics. He was a university lecturer in molecular and cellular biology at the University of Oxford and a fellow of Balliol College from 1995 to 2003. He obtained his degree in genetics at Cambridge in 1985, and his doctorate at Imperial College in 1990. Between 1990 and 1995, he did postdoctoral research at Dundee and at the Massachusetts Institute of Technology’s (MIT’s) Whitehead Institute. His research made use of the advanced genetics of Drosophila to study genome stability by examining the roles of cell cycle regulators in life cycle transitions. His interests broadened into human genetics, genomics, and systems biology through lecturing and from tutoring biochemists, zoologists, and medical students from primary research papers. Helping to establish Oxford’s innovative research M.Sc. in integrative biosciences led Dr. Axton to realize the importance of the integrative overview of biomedical research. As a full-time professional editor, he is now in a position to use this perspective to help coordinate research in genetics.
Jesse A. Berlin, Sc.D., spent 15 years as a faculty member at the University of Pennsylvania, in the Center for Clinical Epidemiology and Biostatistics, under the direction of Dr. Brian Strom. He left the University of Pennsylvania to join Janssen Research & Development, where he is currently vice president of epidemiology. He has authored or coauthored more than 230 publications in a wide variety of clinical and methodological areas, including papers on the study of meta-analytic methods as applied to both randomized trials and epidemiology. He served on an Institute of Medicine committee that developed recently released recommendations for the use of systematic reviews in clinical effectiveness research. He currently serves on the Scientific Advisory Committee to the Observational Medical Outcomes Partnership, a public-private partnership aimed at understanding methodology for assessing drug safety in large administrative databases. He is also a fellow of the American Statistical Association.
Josephine P. Briggs, M.D., is director of the National Center for Complementary and Alternative Medicine (NCCAM), and acting director, Division of Clinical Innovation, National Center for Advancing Transla-